Journal: Anti-cancer Drugs

Possinger K, Kaufmann M, Coleman R, Stuart NSA, Helsing M, Ohnmacht U, Arning M (1999). Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancer. Anti-cancer Drugs 10(2): 155-162. ISSN: 0959-4973. [Abstract]